17β-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages

Arthritis and Rheumatism

Volumn 50, Issue 6, 2004, Pages 1967-1975

  Kramer, P R ^a,b   Kramer, S F ^a   Guan, G ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CYTOKINE; ESTRADIOL; FC RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HORMONAL REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ADULT; ANTIGENS, CD14; CELLS, CULTURED; CYTOKINES; ESTRADIOL; EXTRACELLULAR SPACE; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MIDDLE AGED; MONOCYTES; RECEPTORS, IGE; RECEPTORS, IGG; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642566162     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20309     Document Type: Article

References (48)

1. Mattsson R, Mattsson A, Holmdahl R, Whyte A, Rook GA. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol 1991;85:41-7.
2. Holmdahl R, Jansson L, Meyerson B, Klareskog L. Oestrogen induced suppression of collagen arthritis. I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response. Clin Exp Immunol 1987;70:372-8.
3. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983;12:69-72.
4. Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1976;27:922-7.
5. Hench PS. The ameliorating effect of pregnancy on chronic atrophi (infectious rheumatoid) arthritis, fibrosis and interim heat hydrarthrosis. Mayo Clin Proc 1938;13:161-7.
6. McHugh NJ. Pregnancy loss, menopause, and the onset of rheumatoid arthritis. Ann Rheum Dis 1990;49:817-8.
7. Polan ML, Kuo A, Loukides J, Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J Clin Endocrinol Metab 1990;70:480-4.
8. Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril 1988;49:964-8.
9. Hu SK, Mitcho YL, Rath NC. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol 1988;10:247-52.
10. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994;93:944-50.
11. Shanker G, Sorci-Thomas M, Adams MR. Estrogen modulates the expression of tumor necrosis factor α mRNA in phorbol ester-stimulated human monocytic THP-1 cells. Lymphokine Cytokine Res 1994;13:377-82.
12. Ralston SH, Russell RG, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990;5:983-8.
13. Saklatvala J. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
14. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
15. Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG, et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 1993;36:1305-14.
16. Pettipher ER, Higgs GA, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A 1986;83:8749-53.
17. Henderson B, Pettipher ER. The synovial lining cell: biology and pathobiology. Semin Arthritis Rheum 1985;15:1-32.
18. Cutolo M, Accardo S, Villaggio B, Clerico P, Bagnasco M, Coviello DA, et al. Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+,CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum 1993;36:1087-97.
19. Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Coviello DA, et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996;81:820-7.
20. Kramer PR, Wray S. 17-β-estradiol regulates expression of genes that function in macrophage activation and cholesterol homeostasis. J Steroid Biochem Mol Biol 2002;81:203-16.
21. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor α production by adhered human monocytes: a key role for Fcγ receptor type IIIA in rheumatoid arthritis. Arthritis Rheum 2000;43:608-16.
22. Wirthmueller U, Kurosaki T, Murakami MS, Ravetch JV. Signal transduction by Fcγ RIII (CD16) is mediated through the γ chain. J Exp Med 1992;175:1381-90.
23. Pope RM, Teller DC, Mannik M. The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A 1974;71:517-21.
24. Nardella FA, Teller DC, Mannik M. Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med 1981;154:112-25.
25. Klaassen RJ, Goldschmeding R, Tetteroo PA, Von dem Borne AE. The Fc valency of an immune complex is the decisive factor for binding to low-affinity Fcγ receptors. Eur J Immunol 1988;18:1373-7.
26. Edwards JC, Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol 1998;37:126-30.
27. Bhatia A, Blades S, Cambridge G, Edwards JC. Differential distribution of Fcγ RIIIa in normal human tissues and colocalization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology 1998;94:56-63.
28. Gomez F, Ruiz P, Bernal JA, Escobar M, Garcia-Egido A, Lopez-Saez JJ. Enhancement of splenic-macrophage Fcγ receptor expression by treatment with estrogens. Clin Diagn Lab Immunol 2001;8:806-10.
29. Friedman D, Netti F, Schreiber AD. Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes. J Clin Invest 1985;75:162-7.
30. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995;13:217-26.
31. Young DA, Lowe LD, Clark SC. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture: analysis of macrophage antibody-dependent cellular cytotoxicity. J Immunol 1990;145:607-15.
32. Welch GR, Wong HL, Wahl SM. Selective induction of Fcγ RIII on human monocytes by transforming growth factor-β. J Immunol 1990;144:3444-8.
33. Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998;47:290-301.
34. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998;840:45-50.
35. Wilder RL, Elenkov IJ. Hormonal regulation of tumor necrosis factor-α, interleukin-12 and interleukin-10 production by activated macrophages: a disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann N Y Acad Sci 1999;876:14-31.
36. Kurosaki T, Gander I, Ravetch JV. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proc Natl Acad Sci U S A 1991;88:3837-41.
37. Phillips JH, Chang CW, Lanier LL. Platelet-induced expression of Fcγ RIII (CD16) on human monocytes. Eur J Immunol 1991;21:895-9.
38. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
39. Van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH. Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Ann Rheum Dis 1995;54:33-8.
40. Van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. Ann Rheum Dis 1995;54:674-7.
41. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-7.
42. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
43. Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
44. Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 1999;104:503-13.
45. Krieg SA, Krieg AJ, Shapiro DJ. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1β-converting enzyme (caspase 1). Mol Endocrinol 2001;15:1971-82.
46. Gessner JE, Grussenmeyer T, Kolanus W, Schmidt RE. The human low affinity immunoglobulin G Fc receptor III-A and III-B genes: molecular characterization of the promoter regions. J Biol Chem 1995;270:1350-61.
47. Safe S. Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 2001;62:231-52.
48. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311-7.